Posts Tagged Development
-
MediciNova Receives Notice of Patent Allowance for Method of Treating Acute Exacerbations of Asthma
SAN DIEGO, Dec. 9, 2012 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities Exchange (Code Number: 4875), announced that it has been granted a Notice of Allowance from the U....
-
Genmab’s Financial Calendar for 2013
Company Announcement Copenhagen, Denmark; December 6, 2012 – Genmab A/S (OMX: GEN) announces its financial calendar for 2013 as follows: Any issues from shareholders for the agenda of the Annual General Meeting must be submitted in writing to the Board of Directors no later than Tuesday, Mar...
-
MediciNova Extends MN-166 Patent Position in Europe
SAN DIEGO, Nov. 18, 2012 (GLOBE NEWSWIRE) -- MediciNova Inc, a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities Exchange (Code Number: 4875), today announced that it has received Notices of Allowance from the European Patent Off...
-
Cross Border Resources Announces Financial Results for the Quarter Ended September 30, 2012 and Provides Operational Update
DALLAS, Nov. 16, 2012 (GLOBE NEWSWIRE) -- Cross Border Resources, Inc. (XBOR.OB) (the "Company" or "Cross Border"), a Dallas-based oil and gas exploration and production company, recently filed its financial results for the quarter ended September 30, 2012. Additionally, the Company today is providi...
-
Informatica Launches PowerCenter Big Data Edition
REDWOOD CITY, Calif., Oct. 23, 2012 (GLOBE NEWSWIRE) -- Informatica Corporation (Nasdaq:INFA), the world's number one independent provider of data integration software, today introduced Informatica PowerCenter Big Data Edition, a major innovation for enterprises augmenting traditional transactional...
-
Melco Crown Entertainment Announces Signing of Commitment Letter for Its Senior Secured Credit Facilities for the Development of Studio City
MACAU, Oct. 19, 2012 (GLOBE NEWSWIRE) -- Melco Crown Entertainment Limited ("Melco Crown Entertainment" or "the Company") (SEHK:6883) (Nasdaq:MPEL), a developer and owner of casino gaming and entertainment resort facilities focused on the Macau market, announces that its 60% owned indirect subsidiar...
-
Evotec Receives Milestone in Drug Discovery Collaboration
HAMBURG, Germany, Oct. 8, 2012 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced that it has received a pre-clinical milestone from its Drug Discovery Collaboration with Novartis. No financial details were given. Dr Mario Polywka, Chief Operating Officer of Evotec, said: "We a...
-
Topin & Associates Adds Two Project Managers as Agency Expands
CHICAGO, Oct. 2, 2012 (GLOBE NEWSWIRE) -- Additional assignments from clients have led Topin & Associates (topin.com) to hire an additional team member and promote from within. Heather Chenery joins the agency as senior project manager, and Brianna Anderson is promoted to project manager. As s...
-
Alta Verde Group Completes Three Regional Developments In Palm Springs Coachella Valley
Beverly Hills, CA, Sept. 27, 2012 (GLOBE NEWSWIRE) -- PLEASE NOTE PHONE NUMBER FOR ALTA VERDE IS: 310-286-9200 ** Images Available Upon Request ** Beverly Hills based residential real estate development firm Alta Verde Group (AVG) is rapidly expanding its portfolio of regional properties -- the comp...
-
Cersosimo Lumber Speeds Toward Sustainability, Powered by Turbosteam
BRATTLEBORO, Vt., Sept. 24, 2012 (GLOBE NEWSWIRE) -- Turbosteam has delivered a clean energy system to Cersosimo Lumber, a leading producer of high quality Northeastern Hardwood and Eastern White Pine lumber, at its Brattleboro, Vermont hardwood mill. The project will allow Cersosimo to extract ener...
-
NIH Awards Major Contract to Evotec to Manage and Operate a Small Molecule Repository
NIH Small Molecule Repository HAMBURG, Germany, Sept. 19, 2012 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced that Evotec has entered into a multi-year compound management agreement with the National Institutes of Health (NIH), Department of Health and Human Services, fo...
-
Synergy Pharmaceuticals Acquires FV-100 Shingles Drug From Bristol-Myers Squibb Company
NEW YORK, Aug. 23, 2012 (GLOBE NEWSWIRE) -- Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, today announced that it has signed an Asset Purchase Agreement with Bristol-Myers Squibb Company (NYSE:BMY) and has acquired the assets r...
-
XOMA Receives Orphan Drug Designation From U.S. Food & Drug Administration for Gevokizumab
BERKELEY, Calif., Aug. 22, 2012 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, announced today that gevokizumab, the company's IL-1 beta modulating antibody, has been granted Orphan Drug Designation by the U.S. Food & Drug...
-
Coronado Biosciences to Moderate Diabetes Panel at the 8th Annual Swedish-American Life Science Summit in Stockholm
BURLINGTON, Mass., Aug. 22, 2012 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer, announced today that Dr. Karin Hehenberger, Executive Vi...
-
MediciNova Reports Second Quarter 2012 Results
SAN DIEGO, Aug. 9, 2012 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities Exchange (Code Number: 4875), yesterday reported financial results for the second quarter ended Ju...
